Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis

Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis

Uncorrected serum calcium concentration is the first mineral metabolism metric planned for use as a quality measure in the United States ESRD population. Few studies in patients undergoing either peritoneal dialysis (PD) or hemodialysis (HD) have assessed the association of uncorrected serum calcium...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Nephrology 2015-07, Vol.26 (7), p.1671-1681
Hauptverfasser: Rivara, Matthew B, Ravel, Vanessa, Kalantar-Zadeh, Kamyar, Streja, Elani, Lau, Wei Ling, Nissenson, Allen R, Kestenbaum, Bryan, de Boer, Ian H, Himmelfarb, Jonathan, Mehrotra, Rajnish
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Biomarkers - blood
Cause of Death
Clinical Epidemiology
Databases, Factual
Female
Humans
Hypercalcemia - diagnosis
Hypercalcemia - mortality
Hyperphosphatemia - diagnosis
Hyperphosphatemia - mortality
Kidney Failure, Chronic - diagnosis
Kidney Failure, Chronic - mortality
Kidney Failure, Chronic - therapy
Male
Middle Aged
Peritoneal Dialysis - methods
Peritoneal Dialysis - mortality
Predictive Value of Tests
Renal Dialysis - methods
Renal Dialysis - mortality
Retrospective Studies
Risk Assessment
Serum Albumin - analysis
Survival Analysis
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Uncorrected serum calcium concentration is the first mineral metabolism metric planned for use as a quality measure in the United States ESRD population. Few studies in patients undergoing either peritoneal dialysis (PD) or hemodialysis (HD) have assessed the association of uncorrected serum calcium concentration with clinical outcomes. We obtained data from 129,076 patients on dialysis (PD, 10,066; HD, 119,010) treated in DaVita, Inc. facilities between July 1, 2001, and June 30, 2006. After adjustment for potential confounders, uncorrected serum calcium
ISSN:1046-6673
1533-3450
DOI:10.1681/ASN.2014050472